Figure 2From: The non-invasive 13C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis Cumulative 13 C-exhalation after 1.5 h test time (cPDR 1.5h ) in 99 patients with borderline diagnosis or definite NASH stratified for the presence of advanced (F2-3) fibrosis and 7 patients with complete cirrhotic conversion. p < 0.001 for F0-1 vs. F2-3 in each group and for F0-1 vs. cirrhosis; p < 0.05 for F0-1 with borderline diagnosis vs. F0-1 with definite NASH p = n.s. for F2-3 vs. cirrhosis by Kruskal-Wallis ANOVA and Dunn's post hoc tests.Back to article page